TCL Archive BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile November 23, 1997
TCL Archive NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation March 27, 2009
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006